Trials / Completed
CompletedNCT01466049
New Biomarkers Evaluating Ovarian Cancer
Evaluation of New Biomarker Assays in Ovarian Cancer Patients Presenting to a Generalist With an Adnexal Mass
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 280 (actual)
- Sponsor
- Fujirebio Diagnostics, Inc. · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate new biomarkers for patients presenting to a physician for surgery to remove a mass in their pelvis and to continue to evaluate these types of patients using the ROMA algorithm for post-market benefits.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2014-03-01
- Completion
- 2014-03-01
- First posted
- 2011-11-07
- Last updated
- 2014-08-05
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01466049. Inclusion in this directory is not an endorsement.